Natixis Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$685K Buy
+13,490
New +$629K ﹤0.01% 1463
2025
Q2
Sell
-17,761
Closed -$504K 1665
2025
Q1
$504K Buy
17,761
+7,356
+71% +$261K ﹤0.01% 1454
2024
Q4
$433K Sell
10,405
-1,169
-10% -$55.9K ﹤0.01% 1501
2024
Q3
$773K Sell
11,574
-58,936
-84% -$5.41M ﹤0.01% 1364
2024
Q2
$8.37M Buy
70,510
+40,021
+131% +$5.06M 0.02% 658
2024
Q1
$3.25M Buy
30,489
+5,877
+24% +$592K 0.01% 901
2023
Q4
$2.45M Buy
24,612
+4,688
+24% +$394K 0.01% 944
2023
Q3
$2.06M Buy
19,924
+3,310
+20% +$369K 0.01% 980
2023
Q2
$2.02M Sell
16,614
-12,709
-43% -$1.7M 0.01% 958
2023
Q1
$4.5M Buy
29,323
+573
+2% +$94.5K 0.02% 717
2022
Q4
$5.16M Buy
28,750
+3,313
+13% +$542K 0.02% 675
2022
Q3
$3.01M Buy
25,437
+13,586
+115% +$2.06M 0.01% 768
2022
Q2
$1.69M Sell
11,851
-1,586
-12% -$227K 0.01% 960
2022
Q1
$2.31M Buy
13,437
+3,178
+31% +$535K 0.01% 920
2021
Q4
$2.61M Sell
10,259
-67,297
-87% -$19.7M 0.01% 876
2021
Q3
$29.8M Sell
77,556
-145,991
-65% -$53.8M 0.12% 175
2021
Q2
$52.5M Buy
+223,547
New +$40M 0.25% 95

Other funds holding MRNA